Hospital-Acquired Infections Therapeutics in the UK to Reach USD 683.4 Million by 2035: Rising Antimicrobial Resistance Drive Growth
The demand for hospital-acquired infections (HAIs) therapeutics in the United Kingdom is set for strong expansion over the next decade, supported by increasing infection incidence, rising antimicrobial resistance (AMR), and …
Hospital-Acquired Infections Therapeutics in the UK to Reach USD 683.4 Million by 2035: Rising Antimicrobial Resistance Drive Growth Read More